CAAC

CAAC
Name	Cyclic (Alkyl)(Amino) Carbene
Caption	General structure of a cyclic (alkyl)(amino) carbene
Formula	CxHyN
Molar mass	variable
Appearance	colorless to pale liquids or solids
Melting point	variable
Boiling point	variable
Solubility	soluble in organic solvents

CAAC

Cyclic (alkyl)(amino) carbenes are a class of stable singlet carbenes characterized by a cyclic framework bearing one amino-substituted carbon and one alkyl-substituted carbon adjacent to a divalent carbon center. Invented in the early 21st century, these ligands have found use across organometallic chemistry, catalysis, and small-molecule activation, intersecting research involving N-heterocyclic carbene, Grubbs catalyst, Schrock carbene, Frustrated Lewis pair, and Transition metal complexes. Researchers from institutions such as University of California, Berkeley, Max Planck Institute for Coal Research, University of Strasbourg, and ETH Zurich have contributed to their exploration.

Definition and Nomenclature

Cyclic (alkyl)(amino) carbenes are defined as five- or six-membered heterocycles where a formally divalent carbon center is flanked by an amino-substituted carbon and an alkyl-substituted carbon. Nomenclature often follows IUPAC guidelines and common usage in articles by authors like Guy Bertrand and Anthony J. Arduengo III; specific derivatives are named by ring size and substituents, e.g., CAAC-5 or CAAC-6 variants in literature from Chemical Communications and Journal of the American Chemical Society. Related ligand classes include N-heterocyclic carbene and Singlet carbene families; comparisons are frequent with ligands developed in groups led by Robert H. Grubbs and Richard R. Schrock.

History and Development

The conceptual groundwork for persistent carbenes traces to early theoretical work by Linus Pauling and experimental advances culminating in the isolation of persistent species by Anthony J. Arduengo III. The specific CAAC family emerged through synthetic and mechanistic studies led by Guy Bertrand and collaborators at institutions such as Université Paul Sabatier and University of California, San Diego. Landmarks include applications in olefin metathesis linked to Grubbs catalyst development, radical stabilization studies connected to research by Robert H. Grubbs and K. C. Nicolaou, and small-molecule activation parallel to discoveries from John B. Goodenough and Gerhard Ertl-related fields. Reviews in venues like Chemical Reviews and Accounts of Chemical Research traced rapid expansion into organometallic complexes studied at Massachusetts Institute of Technology, California Institute of Technology, and Imperial College London.

Chemical Structure and Properties

Structurally, CAACs feature a singlet carbene center stabilized by sigma donation from the adjacent alkyl group and pi-donation/acceptance interactions with the adjacent amino substituent. X-ray crystallography performed in labs such as Institut de Science et d'Ingénierie Supramoléculaires and spectroscopic studies from Max Planck Society groups reveal shortened N–C bonds and distinct C–carbene geometries contrasted with N-heterocyclic carbene analogues reported by Anthony J. Arduengo III and Michael L. H. Green. Electronic properties measured by cyclic voltammetry and photoelectron spectroscopy connect to work by John B. Fenn and Ahmed Zewail in adjacent technique development. CAAC ligands exhibit strong sigma-donor and significant pi-acceptor character, impacting bond angles, singlet–triplet gaps examined in theoretical studies by groups at Princeton University and ETH Zurich.

Synthesis and Preparation

Synthetic routes to CAAC precursors and free carbenes typically involve multistep sequences: construction of the cyclic backbone via alkylation and amination strategies seen in methods developed at Université Paul Sabatier and University of Strasbourg, followed by deprotonation or reduction to generate the carbene. Key reagents and transformations parallel those in research from Sigma-Aldrich-sourced protocols and academic labs like Harvard University and University of Cambridge: nucleophilic substitution, cyclization, and base-mediated deprotonation using strong non-nucleophilic bases explored by groups including Pierre H. Dixneuf and Holger Braunschweig. Alternative metal-mediated routes use palladium-catalyzed coupling methods associated with work by Ei-ichi Negishi and Suzuki coupling-related techniques referenced in publications from Journal of Organic Chemistry and Angewandte Chemie.

Reactivity and Applications

CAACs coordinate to transition metals forming complexes with ruthenium, palladium, nickel, gold, and copper that have been applied in catalysis, including olefin metathesis, cross-coupling, and hydrogenation systems explored by labs of Robert H. Grubbs, Richard R. Schrock, and Stephen L. Buchwald. Their unique electronic profile enables stabilization of low-valent species, facilitating small-molecule activation of dinitrogen, carbon dioxide, and dihydrogen in studies related to Chatt cycle-inspired research and work by François Diederich. CAAC-stabilized radicals and main-group species have been reported in collaborations among Max Planck Institute and University of Oxford groups; applications extend to materials chemistry, photoredox catalysis as in studies from Yasunori Yamamoto and David MacMillan, and organocatalysis associated with Benjamin List and David W. C. MacMillan-adjacent fields.

Biological and Toxicological Aspects

Direct biological applications of CAACs are limited; most studies focus on organometallic complexes whose toxicity and biocompatibility are assessed using assays and guidelines developed by organizations such as World Health Organization and U.S. Environmental Protection Agency. Transition-metal CAAC complexes containing palladium or copper raise concerns similar to those described in literature on metal toxicity by researchers at National Institutes of Health and Centers for Disease Control and Prevention. Environmental fate and occupational exposure issues are discussed in industrial hygiene contexts at Occupational Safety and Health Administration-related frameworks. Where CAAC-derived catalysts are used in pharmaceutical synthesis at companies like Pfizer and Roche, standard purification and residual metal analysis following ICH guidelines mitigate adverse biological impact.

Category:Carbenes